AI Verdict
RAMP has stronger fundamentals based on our AI analysis.
RANI vs RAMP Fundamental Comparison
| Metric | RANI | RAMP |
|---|---|---|
| Revenue | $1.6M | $606.8M |
| Net Income | $-29.7M | $75.0M |
| Net Margin | -1,817.1% | 12.4% |
| ROE | -89.9% | 7.8% |
| ROA | -50.6% | 5.9% |
| Current Ratio | 4.21x | 2.72x |
| Debt/Equity | 0.00x | 0.00x |
| EPS | $-0.45 | $1.14 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
RANI vs RAMP: Frequently Asked Questions
Is RANI or RAMP a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), RAMP has stronger fundamentals. RANI is rated SELL (48% confidence) while RAMP is rated HOLD (58% confidence). This is not investment advice.
How does RANI compare to RAMP fundamentally?
Rani Therapeutics Holdings, Inc. has ROE of -89.9% vs LiveRamp Holdings, Inc.'s 7.8%. Net margins are -1,817.1% vs 12.4% respectively.
Which stock pays higher dividends, RANI or RAMP?
RANI has a dividend yield of N/A or no dividend while RAMP has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in RANI or RAMP for long term?
For long-term investing, consider that RANI has SELL rating with 48% confidence, while RAMP has HOLD rating with 58% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about RANI vs RAMP?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RANI vs RAMP, the AI consensus favors RAMP based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.